We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEL
1476
DELISTED
American Equity Investment Life Holding Company
AEL
| $9.85K | ﹤0.01% |
189
+42
| +29% | +$1.69K |
|
1477
Stepan Co
SCL
$1.47B
| $9.84K | ﹤0.01% |
103
+23
| +29% | +$2.19K |
|
1478
Avnet
AVT
$8.02B
| $9.84K | ﹤0.01% |
195
+61
| +46% | +$2.69K |
|
|
DVAX
1479
DELISTED
Dynavax Technologies
DVAX
| $9.83K | ﹤0.01% |
761
+34
| +5% | +$387 |
|
1480
Elbit Systems
ESLT
$39.9B
| $9.82K | ﹤0.01% |
47
-21
| -31% | -$4.07K |
|
1481
Builders FirstSource
BLDR
$7.71B
| $9.79K | ﹤0.01% |
72
-21
| -23% | -$2.33K |
|
1482
LivaNova
LIVN
$4.2B
| $9.77K | ﹤0.01% |
190
+27
| +17% | +$1.27K |
|
|
PRSU
1483
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $9.76K | ﹤0.01% |
363
+351
| +2,925% | +$7.8K |
|
|
TMHC
1484
DELISTED
Taylor Morrison
TMHC
| $9.75K | ﹤0.01% |
200
+13
| +7% | +$560 |
|
|
EHAB
1485
DELISTED
Enhabit
EHAB
| $9.67K | ﹤0.01% |
841
-185
| -18% | -$2.31K |
|
|
PTVE
1486
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $9.61K | ﹤0.01% |
1,270
+1,239
| +3,997% | +$9.46K |
|
|
SPTN
1487
DELISTED
SpartanNash
SPTN
| $9.61K | ﹤0.01% |
427
+93
| +28% | +$2.18K |
|
1488
Suzano
SUZ
$10B
| $9.6K | ﹤0.01% |
1,041
+251
| +32% | +$2.19K |
|
|
UBA
1489
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $9.59K | ﹤0.01% |
451
| – | – |
|
1490
Goodyear
GT
$1.74B
| $9.58K | ﹤0.01% |
700
+162
| +30% | +$2.02K |
|
1491
Vail Resorts
MTN
$5.21B
| $9.57K | ﹤0.01% |
38
+5
| +15% | +$1.22K |
|
1492
Equitable Holdings
EQH
$14.4B
| $9.56K | ﹤0.01% |
352
-69
| -16% | -$1.75K |
|
1493
Iovance Biotherapeutics
IOVA
$2.91B
| $9.55K | ﹤0.01% |
1,356
-1,114
| -45% | -$7.97K |
|
1494
BWX Technologies
BWXT
$15.5B
| $9.52K | ﹤0.01% |
133
+26
| +24% | +$1.7K |
|
1495
Expro Ltd
XPRO
$1.99B
| $9.52K | ﹤0.01% |
537
| – | – |
|
1496
Provident Financial Services
PFS
$3.16B
| $9.51K | ﹤0.01% |
582
| – | – |
|
1497
Avient
AVNT
$4.15B
| $9.45K | ﹤0.01% |
231
-4
| -2% | -$157 |
|
1498
CNO Financial Group
CNO
$5.11B
| $9.42K | ﹤0.01% |
398
-26
| -6% | -$579 |
|
1499
New York Times
NYT
$10.5B
| $9.41K | ﹤0.01% |
239
+7
| +3% | +$266 |
|
1500
NCR Voyix
VYX
$1.12B
| $9.37K | ﹤0.01% |
606
-66
| -10% | -$952 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.